Results 171 to 180 of about 2,022,996 (246)

Extracellular Vesicles in Dermatology: Where Are We and What Lies Ahead?

Experimental Dermatology, Volume 35, Issue 11, November 2026.
ABSTRACT Extracellular vesicles (EVs) have emerged as key players in skin biology, mediating intercellular communication across diverse physiological and pathological contexts. In this review, we critically assess the current understanding of EVs in dermatology, highlighting their roles in skin homeostasis, ageing, inflammation, wound healing and ...
Ines Martic, Alessandro Paolini, Stefania Paola Bruno, Andrea Gallego, Dorottya Ádám, Sedat Odabas, Şebnem Erçelen Ceylan, Emanuela Camera, Paloma Pérez, Attila Oláh, Andrea Masotti, Mirjana Nacka‐Aleksić, Danuta Gutowska‐Owsiak, Nsrein Ali, Maria Cavinato   +14 more
wiley   +1 more source

An Australian Narrative Review of Adoptive Cellular Therapies in Malignancy: Expanding Indications, Referral Pathways and Safety Beyond Specialist Centres

Medical Journal of Australia, Volume 224, Issue 11, November 2026.
ABSTRACT Adoptive cellular therapies (ACT), including tumour‐infiltrating lymphocyte (TIL), T‐cell receptor‐engineered T (TCR‐T) cell and chimeric antigen receptor T‐cell (CAR‐T) therapies, represent an evolving class of immunotherapies with established efficacy in selected haematological malignancies and emerging applications in solid tumours ...
Sarah Childs, David Ma, Anthony Rodrigues, Jennifer Massey, Rasha Cosman, Venessa Chin, Laila Girgis, James Lynam, Peter Lau, Barbara Withers, Anthony M. Joshua, Ben Tran, Jayesh Desai, Simon J. Harrison, John Moore, Jia Liu   +15 more
wiley   +1 more source

Decoding neoantigen-encoding tumor-specific transcripts unveils a shared target reservoir for immunotherapy in hepatocellular carcinoma. [PDF]

J Immunother Cancer
Lin P, Wen Y, Zhao J, Zhang F, Su Y, He H, Yu H, Li Q, Liu C, Hu Z, Li Y, Fang Z, Liang L, Huang S.   +13 more
europepmc   +1 more source

Computational Methods for Tumor Neoantigen Profiling from Transcriptomic Data

Cancer cells accumulate somatic mutations that can generate neoantigens recognizable by the immune system, providing the foundation for immunotherapies such as checkpoint inhibitors and personalized cancer vaccines.
DANILO TATONI
core  

Evaluation of Computational Neoantigen Prioritization Strategies for Personalized Cancer Vaccines. [PDF]

Vaccines (Basel)
Zyrin V, Mozheiko E, Valiev I, Lazarev A, Gevorkyan T, Murashko M, Okonechnikov K.   +6 more
europepmc   +1 more source

Nanotechnology-Enabled Immunotherapy for Colorectal Cancer: Overcoming the "Cold" Tumor Microenvironment in Microsatellite-Stable Disease. [PDF]

Int J Nanomedicine
Xu J, Yu J, Liu G, Zhang H, Shen Y, Tang J, Zhou J.   +6 more
europepmc   +1 more source

AI-driven precision immunotherapy: emerging trends from AACR 2026. [PDF]

Biomark Res
Chen Y, Chen M, Xi Y, Xia Y, Ma S, Chen B.   +5 more
europepmc   +1 more source

Targeting molecular residual disease and immune escape in colorectal cancer recurrence: biomarker-guided immunotherapy and cell therapies. [PDF]

Front Med (Lausanne)
Shan Y, Zhang X, Liu J, Hu B, Yang L, Wang H, Li J, Jiang Z, Gong G.   +8 more
europepmc   +1 more source

Fibrinogen alpha chain is associated with response to immune checkpoint inhibitors in non-small cell lung cancer: a multi-cohort discovery and validation study. [PDF]

J Transl Med
Liang H, Xu Y, Chen M, Zhao J, Zhong W, Wang M.   +5 more
europepmc   +1 more source

Advances in immunotherapy for gastrointestinal malignancies. [PDF]

Front Immunol
Liu B, Wang L, Ma Y, Xu W, Chen X, Chi Z, Xing B.   +6 more
europepmc   +1 more source